Bladder, Kidney and Prostate Cancer Clinical Trials and Research

Norton Cancer Institute is at the forefront of cancer treatment research. As principal investigators on numerous trials, our specialist physicians have access to innovative treatments and numerous bladder cancer, urothelial cancer and genitourinary cancer clinical trials and studies.

Learn more about participating in a clinical trial at Norton Healthcare.

Current Bladder, Kidney, Prostate and other Genitourinary Cancer Published Research from Norton Cancer Institute Physicians

Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey
Persistent Müllerian Duct Syndrome and Concurrent Pre-Germ Cell Neoplasia In Situ
Trastuzumab Deruxtecan with Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study
TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic Urothelial Cancer Progressing After Previous Checkpoint Inhibitor Therapy
Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer

Bladder, Kidney and Prostate Cancer Clinical Trials and Research

Bladder, Kidney and Prostate Cancer Clinical Trials and Research

Current Bladder, Kidney, Prostate and other Genitourinary Cancer Published Research from Norton Cancer Institute Physicians

Related Stories

From caregiver to survivor: Shepherdsville woman’s journey shows why cancer screenings save lives

Quick, painless scan could be first step toward beating lung cancer

This two-minute test could be your first line of defense against breast cancer

Norton Healthcare first in Kentucky to unveil new treatment for pancreatic cancer